Hong Kong Exchange filings show that on September 4, Lazard Asset Management LLC increased its holdings in SINOPHARM (01099) by 959,600 shares, at an average price of HK$15.6782 per share, for a total transaction value of approximately HK$15.04 million.

Following the acquisition, the fund's latest share count stands at roughly 188 million shares, representing a 14% ownership stake in the company.